...
首页> 外文期刊>Virchows Archiv >Expression of PAR-4 and PHLDA1 is prognostic for overall and disease-free survival in oral squamous cell carcinomas
【24h】

Expression of PAR-4 and PHLDA1 is prognostic for overall and disease-free survival in oral squamous cell carcinomas

机译:PAR-4和PHLDA1的表达可预测口腔鳞状细胞癌的总体生存率和无病生存期

获取原文
获取原文并翻译 | 示例
           

摘要

PAR-4 is a tumor suppressor protein with a pro-apoptotic function and down-regulation of PAR-4 is seen in a variety of tumors. PHLDA1 gene overexpression has been shown to reduce cell proliferation and induce cell death in a variety of cell types. In this study, 229 cases of oral squamous cell carcinoma (OSCC), arranged in a tissue microarray, were analyzed by immunohistochemistry. PAR-4 expression was predominantly moderate to strong and expression of PHLDA1 was predominantly negative or weak. Cytoplasmic expression of PAR-4 was associated with advanced clinical stage. Expression of PHLDA1 was associated with advanced clinical stage of the tumour. Five-year overall and disease-free survival rates differed significantly between cases that did and cases that did not express PHLDA1, and by multivariate analysis, expression of PHLDA1 and PAR-4 were independent prognostic factors in OSCC patients. Expression of PAR-4 and PHLDA1 is altered in OSCC and might be a valuable prognostic indicator for this disease.
机译:PAR-4是一种具有促凋亡功能的肿瘤抑制蛋白,在多种肿瘤中都可以看到PAR-4的下调。 PHLDA1基因过表达可减少多种细胞类型的细胞增殖并诱导细胞死亡。在这项研究中,通过免疫组织化学分析了229例口腔鳞状细胞癌(OSCC),排列在组织芯片中。 PAR-4的表达主要为中等至强,而PHLDA1的表达则主要为负或弱。 PAR-4的细胞质表达与晚期临床阶段有关。 PHLDA1的表达与肿瘤的晚期临床阶段有关。表达PHLDA1的病例与不表达PHLDA1的病例的五年总体生存率和无病生存率显着不同,并且通过多变量分析,PHLDA1和PAR-4的表达是OSCC患者的独立预后因素。 PAR-4和PHLDA1的表达在OSCC中发生改变,可能是该疾病的重要预后指标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号